2006年3月第3期
·07/05/10 Association Between Carotid Plaque Characteristics and Subsequent Ischemic Cerebrovascular Events
·07/05/10 Distinguishing Between Stroke and Mimic at the Bedside
·07/05/10 Correlation of Cerebrovascular Symptoms and Microembolic Signals With the Stratified Gray-Scale Median Analysis and Color Mapping of the Carotid Plaque
·07/05/10 Upregulated Expression of 14-3-3 Proteins in Astrocytes From Human Cerebrovascular Ischemic Lesions
·07/05/10 Impact of White Matter Hyperintensities Scoring Method on Correlations With Clinical Data
·07/05/10 Internal and Cortical Border-Zone Infarction
·07/05/10 Hemorrhage in the Interventional Management of Stroke Study
·07/05/10 Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients
·07/05/10 Therapeutic Strategies After Examination by Transesophageal Echocardiography in 503 Patients With Ischemic Stroke
·07/05/10 Consumer Involvement in the Design of a Randomized Controlled Trial of Routine Oxygen Supplementation After Acute Stroke
·07/05/10 Anterior-Posterior Ground Reaction Forces as a Measure of Paretic Leg Contribution in Hemiparetic Walking
·07/05/10 Greater Incidence of Both Fatal and Nonfatal Strokes in Disadvantaged Areas
·07/05/10 Interobserver Agreement for the Bedside Clinical Assessment of Suspected Stroke
·07/05/10 Hydrogen Sulfide Is a Mediator of Cerebral Ischemic Damage
·07/05/10 Peroxynitrite Diminishes Myogenic Activity and Is Associated With Decreased Vascular Smooth Muscle F-Actin in Rat Posterior Cerebral Arteries
·07/05/10 Stroke Onset Time Using Sodium MRI in Rat Focal Cerebral Ischemia
·07/05/10 Impaired Progression of Cerebral Aneurysms in Interleukin-1–Deficient Mice
·07/05/10 Ten-Year Incidence of Retinal Emboli in an Older Population
·07/05/10 SERPINA3 Polymorphism Is Not Associated With Primary Intracerebral Hemorrhage in a Polish Population
·07/05/10 Cerebral Microhemorrhages Predict New Disabling or Fatal Strokes in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
·07/05/10 Role of CT Angiography in Thrombolysis Decision-Making for Patients With Presumed Seizure at Stroke Onset
·07/05/10 A Pilot Study of a New Thrombolytic Agent for Acute Ischemic Stroke in Taiwan Within A Five-Hour Window
·07/05/10 Using Change in the National Institutes of Health Stroke Scale to Measure Treatment Effect in Acute Stroke Trials
·07/05/10 Characteristics of an "Ill-Defined" Diagnosis for Stroke
·07/05/10 Seropositivity to Chlamydia pneumoniae Is Associated With Risk of First Ischemic Stroke
·07/05/10 Chronic Chlamydia pneumoniae Infection and Stroke in Cameroon
·07/05/10 Comparison of the Internal Carotid Artery Resistive Index With the Common Carotid Artery Intima-Media Thickness
·07/05/10 Metabolic Syndrome and the Risk of Stroke in Middle-Aged Men
·07/05/10 Subclinical Carotid Atherosclerosis in HIV-Infected Patients
·07/05/10 Distinguishing Between Stroke and Mimic at the Bedside
·07/05/10 Correlation of Cerebrovascular Symptoms and Microembolic Signals With the Stratified Gray-Scale Median Analysis and Color Mapping of the Carotid Plaque
·07/05/10 Upregulated Expression of 14-3-3 Proteins in Astrocytes From Human Cerebrovascular Ischemic Lesions
·07/05/10 Impact of White Matter Hyperintensities Scoring Method on Correlations With Clinical Data
·07/05/10 Internal and Cortical Border-Zone Infarction
·07/05/10 Hemorrhage in the Interventional Management of Stroke Study
·07/05/10 Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients
·07/05/10 Therapeutic Strategies After Examination by Transesophageal Echocardiography in 503 Patients With Ischemic Stroke
·07/05/10 Consumer Involvement in the Design of a Randomized Controlled Trial of Routine Oxygen Supplementation After Acute Stroke
·07/05/10 Anterior-Posterior Ground Reaction Forces as a Measure of Paretic Leg Contribution in Hemiparetic Walking
·07/05/10 Greater Incidence of Both Fatal and Nonfatal Strokes in Disadvantaged Areas
·07/05/10 Interobserver Agreement for the Bedside Clinical Assessment of Suspected Stroke
·07/05/10 Hydrogen Sulfide Is a Mediator of Cerebral Ischemic Damage
·07/05/10 Peroxynitrite Diminishes Myogenic Activity and Is Associated With Decreased Vascular Smooth Muscle F-Actin in Rat Posterior Cerebral Arteries
·07/05/10 Stroke Onset Time Using Sodium MRI in Rat Focal Cerebral Ischemia
·07/05/10 Impaired Progression of Cerebral Aneurysms in Interleukin-1–Deficient Mice
·07/05/10 Ten-Year Incidence of Retinal Emboli in an Older Population
·07/05/10 SERPINA3 Polymorphism Is Not Associated With Primary Intracerebral Hemorrhage in a Polish Population
·07/05/10 Cerebral Microhemorrhages Predict New Disabling or Fatal Strokes in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
·07/05/10 Role of CT Angiography in Thrombolysis Decision-Making for Patients With Presumed Seizure at Stroke Onset
·07/05/10 A Pilot Study of a New Thrombolytic Agent for Acute Ischemic Stroke in Taiwan Within A Five-Hour Window
·07/05/10 Using Change in the National Institutes of Health Stroke Scale to Measure Treatment Effect in Acute Stroke Trials
·07/05/10 Characteristics of an "Ill-Defined" Diagnosis for Stroke
·07/05/10 Seropositivity to Chlamydia pneumoniae Is Associated With Risk of First Ischemic Stroke
·07/05/10 Chronic Chlamydia pneumoniae Infection and Stroke in Cameroon
·07/05/10 Comparison of the Internal Carotid Artery Resistive Index With the Common Carotid Artery Intima-Media Thickness
·07/05/10 Metabolic Syndrome and the Risk of Stroke in Middle-Aged Men
·07/05/10 Subclinical Carotid Atherosclerosis in HIV-Infected Patients